[1]
I.S.V. Manvita, “A prospective cross sectional observational study on prevalence of clinical manifestations and hormonal abnormalities associated with polycystic ovarian disease: https://doi.org/10.54037/WJPS.2021.91211”, World J Pharm Sci, vol. 9, no. 12, pp. 212–217, Dec. 2021.